acamprosate (Campral)

DRUG4 trials

Sponsors

Yale University, University of North Carolina, Chapel Hill, University of New Mexico

Conditions

Alcohol DependenceAlcoholism

Phase 2

Acamprosate Treatment: Mechanisms of Action

CompletedNCT00004552

Yale UniversityAlcoholism

End: 2002-12-31Target: 120Updated: 2015-07-02

Phase 3

COMBINE (Acamprosate/Naltrexone)

CompletedNCT00006206

University of North Carolina, Chapel HillAlcoholism

Start: 1997-08-31End: 2006-05-31Target: 1375Updated: 2010-05-03

Phase 4

Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic

CompletedNCT00381043

University of North Carolina, Chapel HillAlcohol Dependence

Start: 2006-08-31End: 2008-07-31Updated: 2017-05-17

Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE)

WithdrawnNCT00655967

University of New MexicoAlcohol Dependence

Start: 2006-12-31End: 2006-12-31Updated: 2023-08-01

Related Papers

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials

JAMA Psychiatry2019-03-13110 citations

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

2008-02-01300 citations

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

2006-05-011160 citations